Status:
COMPLETED
Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement
Lead Sponsor:
Drägerwerk AG & Co. KGaA
Conditions:
Transcatheter Aortic Valve Replacement
Eligibility:
All Genders
18+ years
Brief Summary
Percutaneous catheter-assisted valve replacement in aortic position (TAVI) for patients with high perioperative risk has become a standard method in recent years. In addition to the detection of bleed...
Eligibility Criteria
Inclusion
- High-flow oxygen therapy after TAVI
Exclusion
- patients without consent
- age \< 18 years
Key Trial Info
Start Date :
October 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 23 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04489914
Start Date
October 12 2020
End Date
April 23 2021
Last Update
August 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Schleswig-Holstein
Lübeck, Germany, 23538